Thromboangiitis obliterans (TAO) is a thrombotic-occlusive as well as an inflammatory peripheral vascular disease with unknown etiology. Recent evidence has supported the immunopathogenesis of the disease, however, the factors contributing to the altered immune function and vascular tissue inflammation are still unclear. This review was intended to collate the more current knowledge on the regulatory molecules involved in TAO from an immunoreactive perspective. The homeostasis of the immune system as well as a variety of progenitor cell populations appear to be affected during TAO and these alterations are associated with intrinsic signaling defects that are directing to an improved understanding of the crosstalk between angiogenesis and the immune system, as well as the potential of new co-targeting strategies applying both immunotherapy and angiogenic therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528722 | PMC |
| http://dx.doi.org/10.22038/ijbms.2019.31119.7513 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tetrahydrocannabinol vape-associated cannabis arteritis in a patient with minimal tobacco exposure.
J Vasc Surg Cases Innov Tech
February 2025
Division of Vascular Surgery, Department of Surgery, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Thromboangiitis obliterans (TAO) is an inflammatory vasculopathy that often presents in young men with substantial tobacco use. Cannabis arteritis is the cannabis-associated counterpart, but there remains controversy over its classification due to overwhelming concurrent tobacco use. A 31-year-old man developed lifestyle-limiting claudication that coincided with vaping high-potency tetrahydrocannabinol.
View Article and Find Full Text PDFDistinct patient characteristics are associated with clinical presentation and prognosis in thromboangiitis obliterans.
Vasa
January 2025
Department of Cardiology and Angiology, University Hospital Tübingen, Germany.
Thromboangiitis obliterans (TAO) is a rare but threatening disease associated with significant morbidity and mortality. The pathophysiology is poorly understood, the diagnosis is often obscure and causal treatment options are limited. In the current study, we aimed to identify distinct TAO patient clusters that differed in clinical presentation and prognosis.
View Article and Find Full Text PDFThromboangiitis Obliterans (Buerger's Disease).
QJM
November 2024
Department of Rheumatology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-minami-machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Elevation and distraction of the Tibial periosteum in the management of chronic ischemic lower limb diseases.
J Orthop Surg (Hong Kong)
October 2024
Department of Orthopaedics, Yueyang Central Hospital, Yueyang, People's Repulic of China.
Objective: This study investigates the effectiveness of tibia periosteum distraction (TPD) applied to the tibial periosteum, an innovative approach grounded in Ilizarov's tension-stress theory, for the treatment of ischemic diabetic foot and vasculitic foot conditions.
Methods: A retrospective analysis was conducted on 33 patients (36 limbs) who underwent TPD between June 2019 and May 2022. The study comprised 21 males (23 limbs) and 12 females (13 limbs), aged 41 to 80 years (mean age: 63.
[Preliminary application of ulnar cortex transverse transport technique in treatment of upper extremity thromboangiitis obliterans].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
October 2024
Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi Guizhou, 563003, P. R. China.
Article Synopsis
- - The study aimed to evaluate the feasibility and effectiveness of the ulnar cortex transverse transport technique for treating upper extremity thromboangiitis obliterans (TAO) in 7 male patients aged 32 to 50, all suffering from severe symptoms including finger ulcers.
- - A retrospective analysis of pre- and post-operative data showed successful healing of ulcers within an average of 17.3 days, with no complications or recurrence of ulcers noted during the 1-year follow-up.
- - Patients reported significant pain relief, with the disappearance of rest pain taking an average of 12.1 days, and serum IL-6 levels were measured to assess inflammation before and after the procedure.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!